Terug
Dagbereik
€ 24,23
€ 24,99
52-Weeksbereik
€ 8,02
€ 27,72
Volume
2.999.321
50D / 200D Gem.
€ 24,58
/
€ 20,18
Vorige Slotkoers
€ 23,98
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -52,4 | 0,4 |
| P/B | 1,9 | 2,9 |
| ROE % | -3,7 | 3,8 |
| Net Margin % | -4,9 | 3,9 |
| Rev Growth 5Y % | -0,3 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 27,88
+14.1%
Low: € 22,00
High: € 30,00
Forward K/W
23,7
Forward WPA
€ 1,03
WPA Groei (sch.)
+0,0%
Omzet Sch.
5 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,53
€ 1,50 – € 1,54
|
6 B | 2 |
| FY2029 |
€ 1,44
€ 1,42 – € 1,45
|
5,8 B | 4 |
| FY2028 |
€ 1,33
€ 0,36 – € 2,38
|
5,5 B | 6 |
Belangrijkste Punten
Revenue declined -0,26% annually over 5 years
Earnings declined -168,64% over the past year
Generating 284,00M in free cash flow
PEG of 0,29 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,48%
Capital efficient — spends only 5,85% of revenue on capex
Groei
Revenue Growth (5Y)
-0,26%
Revenue (1Y)6,22%
Earnings (1Y)-168,64%
FCF Growth (3Y)55,80%
Kwaliteit
Return on Equity
-3,67%
ROIC1,79%
Net Margin-4,92%
Op. Margin5,34%
Veiligheid
Debt / Equity
0,61
Current Ratio2,17
Interest Coverage1,15
Waardering
P/E Ratio
-52,37
P/B Ratio1,86
EV/EBITDA62,00
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,22% | Revenue Growth (3Y) | 3,32% |
| Earnings Growth (1Y) | -168,64% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0,26% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,72B | Net Income (TTM) | -232,00M |
| ROE | -3,67% | ROA | -1,74% |
| Gross Margin | 43,48% | Operating Margin | 5,34% |
| Net Margin | -4,92% | Free Cash Flow (TTM) | 284,00M |
| ROIC | 1,79% | FCF Growth (3Y) | 55,80% |
| Safety | |||
| Debt / Equity | 0,61 | Current Ratio | 2,17 |
| Interest Coverage | 1,15 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -52,37 | P/B Ratio | 1,86 |
| P/S Ratio | 2,58 | PEG Ratio | 0,29 |
| EV/EBITDA | 62,00 | Dividend Yield | 0,00% |
| Market Cap | 12,15B | Enterprise Value | 15,62B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,72B | 4,44B | 4,42B | 4,41B | 4,76B |
| Net Income | -232,00M | 338,00M | -1,23B | -78,00M | -483,00M |
| EPS (Diluted) | -0,47 | 0,68 | -2,50 | -0,15 | -0,97 |
| Gross Profit | 2,05B | 1,91B | 1,94B | 1,97B | 2,08B |
| Operating Income | 252,00M | 251,00M | 326,00M | 384,00M | 304,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13,36B | 12,61B | 14,36B | 15,49B | 16,48B |
| Total Liabilities | 6,81B | 6,52B | 8,14B | 8,20B | 8,97B |
| Shareholders' Equity | 6,55B | 6,10B | 6,22B | 7,29B | 7,51B |
| Total Debt | 4,02B | 4,32B | 5,77B | 5,84B | 6,32B |
| Cash & Equivalents | 545,00M | 468,00M | 352,00M | 345,00M | 638,00M |
| Current Assets | 3,46B | 3,22B | 3,41B | 3,28B | 3,27B |
| Current Liabilities | 1,60B | 1,32B | 1,24B | 1,70B | 1,65B |